Even if the importance of angiotensinogen (AGT) gene has been known in gene
targeting animals and humans genetic studies, its precise mechanism and th
e interaction among AGT gene variants, plasma AGT concentration and risk fo
r hypertension remain uncertain. We examined whether AGT gene variants pred
ispose to hypertension via an increase of plasma AGT concentration. Plasma
AGT concentration was estimated from plasma angiotensin I which was cleaved
by an excess amount of human renin and measured by RTA. Using 9 AGT gene v
ariants which included new polymorphisms (G-152A and T+31C), we examined th
e association with hypertension and with plasma concentration by a case-con
trol study. Haplotype analysis revealed that G-6A, T+31C and M235T polymorp
hisms were in absolute linkage disequilibrium and were associated with hype
rtension but not with plasma AGT level. On the other hand, -1074t;T235 hapl
otype was associated with an increase of AGT level but not with hypertensio
n. In the haplotype analysis, only H3 haplotype frequency, which contained
G-6, T+31 and M235 alleles, was significantly increased in normotensive sub
jects, suggesting that this haplotype is associated with a hypotensive effe
ct. According to combined haplotype analysis of diallele and microsatellite
markers, it remains a possibility that M235T, T+31C, G-6A, A-20C and G-107
4T polymorphisms may play an important role in increased risk for essential
hypertension. Our results suggest that the positive association between AG
T polymorphism and hypertension is not simply explained by an increase of p
lasma AGT concentration. (C) 2000 Elsevier Science Inc. All rights reserved
.